Cargando…
Vulnerable Atherosclerotic Plaque: Is There a Molecular Signature?
Atherosclerosis and its clinical manifestations, coronary and cerebral artery diseases, are the most common cause of death worldwide. The main pathophysiological mechanism for these complications is the rupture of vulnerable atherosclerotic plaques and subsequent thrombosis. Pathological studies of...
Autores principales: | Chiorescu, Roxana Mihaela, Mocan, Mihaela, Inceu, Andreea Ioana, Buda, Andreea Paula, Blendea, Dan, Vlaicu, Sonia Irina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656166/ https://www.ncbi.nlm.nih.gov/pubmed/36362423 http://dx.doi.org/10.3390/ijms232113638 |
Ejemplares similares
-
Biomarkers of Volume Overload and Edema in Heart Failure With Reduced Ejection Fraction
por: Chiorescu, Roxana Mihaela, et al.
Publicado: (2022) -
Osteopontin and osteoprotegerin in atherosclerotic plaque – are they significant markers of plaque vulnerability?
por: Strobescu-Ciobanu, Cristina, et al.
Publicado: (2020) -
Arguments for Using Direct Oral Anticoagulants in Cancer-Related Venous Thromboembolism
por: Chiorescu, Roxana Mihaela, et al.
Publicado: (2021) -
Electrocardiographic Patterns in Patients with Neurally Mediated Syncope
por: Țentea, Călina-Patricia, et al.
Publicado: (2021) -
Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models
por: Gargiulo, Sara, et al.
Publicado: (2016)